TRV GP III, LLC
- SEC CIK
- 0001637299
- Latest filing
- Feb 14, 2024
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 12, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 7
- 0 vs. Q1 2022
- Portfolio value
- $244.5M
- −$124.0M (−33.7%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | COM | 5,104,130 | $99.5M | 40.7% | −419,901−7.6% | Reduced | History |
| PLRXPliant Therapeutics, Inc. | COM | 5,839,160 | $46.8M | 19.1% | 00.0% | Unchanged | History |
| VYGRVoyager Therapeutics, Inc. | COM | 6,391,176 | $37.8M | 15.4% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 1,922,549 | $24.4M | 10.0% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 3,962,202 | $19.4M | 7.9% | 00.0% | Unchanged | History |
| DBTXDecibel Therapeutics, Inc. | COM | 3,139,685 | $13.2M | 5.4% | 00.0% | Unchanged | History |
| JNCEJounce Therapeutics, Inc. | COM | 1,148,780 | $3.48M | 1.4% | 00.0% | Unchanged | History |